ARIES 1 and ARIES 2: Ambrisentan in PAH - A Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter, Efficacy Study of Ambrisentan in Subjects With Pulmonary Arterial Hypertension
Phase of Trial: Phase III
Latest Information Update: 11 Nov 2015
At a glance
- Drugs Ambrisentan (Primary)
- Indications Pulmonary arterial hypertension; Pulmonary hypertension
- Focus Therapeutic Use
- Acronyms ARIES1; ARIES2
- Sponsors Gilead Sciences
- 30 May 2008 Results published in Circulation.
- 30 May 2008 Status changed from in progress to completed.
- 21 May 2008 Results presented at ATS 2008.